Global Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Pipeline Report 2016 - Review of 108 Companies & Their Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Chronic Obstructive Pulmonary Disease (COPD) Overview
  3. Therapeutics Development
  4. Pipeline Products for Chronic Obstructive Pulmonary Disease (COPD) - Overview
  5. Pipeline Products for Chronic Obstructive Pulmonary Disease (COPD) - Comparative Analysis
  6. Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics under Development by Companies
  7. Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics under Investigation by Universities/Institutes
  8. Chronic Obstructive Pulmonary Disease (COPD) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Chronic Obstructive Pulmonary Disease (COPD) - Products under Development by Companies
  13. Chronic Obstructive Pulmonary Disease (COPD) - Products under Investigation by Universities/Institutes
  14. Chronic Obstructive Pulmonary Disease (COPD) - Companies Involved in Therapeutics Development
  • AB2 Bio Ltd.
  • Abeona Therapeutics, Inc.
  • Ache Laboratorios Farmaceuticos S/A
  • Achillion Pharmaceuticals, Inc.
  • Adamis Pharmaceuticals Corporation
  • Advinus Therapeutics Ltd.
  • Alchemia Limited
  • AlgiPharma AS
  • Allinky Biopharma
  • Amakem NV
  • Ampio Pharmaceuticals, Inc.
  • Angion Biomedica Corp.
  • Apellis Pharmaceuticals, Inc.
  • Aridis Pharmaceuticals LLC
  • Ario Pharma Ltd
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Asubio Pharma Co., Ltd.
  • Axikin Pharmaceuticals, Inc.
  • Beech Tree Labs, Inc.
  • Bioneer Corporation
  • Biotie Therapies Corp.
  • Boehringer Ingelheim GmbH
  • C4X Discovery Holdings PLC
  • Carolus Therapeutics, Inc.
  • Cellular Biomedicine Group, Inc.
  • Chiesi Farmaceutici SpA
  • Circassia Pharmaceuticals Plc
  • CSL Limited
  • Cytokinetics, Inc.
  • Daiichi Sankyo Company, Limited
  • Domainex Limited
  • Dong Wha Pharma Co., Ltd.
  • Elsalys Biotech SAS
  • enGene, Inc

For more information visit http://www.researchandmarkets.com/research/pdmhmv/chronic

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Respiratory Drugs, Bronchitis Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Respiratory Drugs, Bronchitis Drugs